-
Towards quantum-enabled cell-centric therapeutics
Authors:
Saugata Basu,
Jannis Born,
Aritra Bose,
Sara Capponi,
Dimitra Chalkia,
Timothy A Chan,
Hakan Doga,
Frederik F. Flother,
Gad Getz,
Mark Goldsmith,
Tanvi Gujarati,
Aldo Guzman-Saenz,
Dimitrios Iliopoulos,
Gavin O. Jones,
Stefan Knecht,
Dhiraj Madan,
Sabrina Maniscalco,
Nicola Mariella,
Joseph A. Morrone,
Khadijeh Najafi,
Pushpak Pati,
Daniel Platt,
Maria Anna Rapsomaniki,
Anupama Ray,
Kahn Rhrissorrakrai
, et al. (8 additional authors not shown)
Abstract:
In recent years, there has been tremendous progress in the development of quantum computing hardware, algorithms and services leading to the expectation that in the near future quantum computers will be capable of performing simulations for natural science applications, operations research, and machine learning at scales mostly inaccessible to classical computers. Whereas the impact of quantum com…
▽ More
In recent years, there has been tremendous progress in the development of quantum computing hardware, algorithms and services leading to the expectation that in the near future quantum computers will be capable of performing simulations for natural science applications, operations research, and machine learning at scales mostly inaccessible to classical computers. Whereas the impact of quantum computing has already started to be recognized in fields such as cryptanalysis, natural science simulations, and optimization among others, very little is known about the full potential of quantum computing simulations and machine learning in the realm of healthcare and life science (HCLS). Herein, we discuss the transformational changes we expect from the use of quantum computation for HCLS research, more specifically in the field of cell-centric therapeutics. Moreover, we identify and elaborate open problems in cell engineering, tissue modeling, perturbation modeling, and bio-topology while discussing candidate quantum algorithms for research on these topics and their potential advantages over classical computational approaches.
△ Less
Submitted 1 August, 2023; v1 submitted 11 July, 2023;
originally announced July 2023.
-
BRACS: A Dataset for BReAst Carcinoma Subtyping in H&E Histology Images
Authors:
Nadia Brancati,
Anna Maria Anniciello,
Pushpak Pati,
Daniel Riccio,
Giosuè Scognamiglio,
Guillaume Jaume,
Giuseppe De Pietro,
Maurizio Di Bonito,
Antonio Foncubierta,
Gerardo Botti,
Maria Gabrani,
Florinda Feroce,
Maria Frucci
Abstract:
Breast cancer is the most commonly diagnosed cancer and registers the highest number of deaths for women with cancer. Recent advancements in diagnostic activities combined with large-scale screening policies have significantly lowered the mortality rates for breast cancer patients. However, the manual inspection of tissue slides by the pathologists is cumbersome, time-consuming, and is subject to…
▽ More
Breast cancer is the most commonly diagnosed cancer and registers the highest number of deaths for women with cancer. Recent advancements in diagnostic activities combined with large-scale screening policies have significantly lowered the mortality rates for breast cancer patients. However, the manual inspection of tissue slides by the pathologists is cumbersome, time-consuming, and is subject to significant inter- and intra-observer variability. Recently, the advent of whole-slide scanning systems have empowered the rapid digitization of pathology slides, and enabled to develop digital workflows. These advances further enable to leverage Artificial Intelligence (AI) to assist, automate, and augment pathological diagnosis. But the AI techniques, especially Deep Learning (DL), require a large amount of high-quality annotated data to learn from. Constructing such task-specific datasets poses several challenges, such as, data-acquisition level constrains, time-consuming and expensive annotations, and anonymization of private information. In this paper, we introduce the BReAst Carcinoma Subtyping (BRACS) dataset, a large cohort of annotated Hematoxylin & Eosin (H&E)-stained images to facilitate the characterization of breast lesions. BRACS contains 547 Whole-Slide Images (WSIs), and 4539 Regions of Interest (ROIs) extracted from the WSIs. Each WSI, and respective ROIs, are annotated by the consensus of three board-certified pathologists into different lesion categories. Specifically, BRACS includes three lesion types, i.e., benign, malignant and atypical, which are further subtyped into seven categories. It is, to the best of our knowledge, the largest annotated dataset for breast cancer subtyping both at WSI- and ROI-level. Further, by including the understudied atypical lesions, BRACS offers an unique opportunity for leveraging AI to better understand their characteristics.
△ Less
Submitted 8 November, 2021;
originally announced November 2021.
-
Mitosis Detection Under Limited Annotation: A Joint Learning Approach
Authors:
Pushpak Pati,
Antonio Foncubierta-Rodriguez,
Orcun Goksel,
Maria Gabrani
Abstract:
Mitotic counting is a vital prognostic marker of tumor proliferation in breast cancer. Deep learning-based mitotic detection is on par with pathologists, but it requires large labeled data for training. We propose a deep classification framework for enhancing mitosis detection by leveraging class label information, via softmax loss, and spatial distribution information among samples, via distance…
▽ More
Mitotic counting is a vital prognostic marker of tumor proliferation in breast cancer. Deep learning-based mitotic detection is on par with pathologists, but it requires large labeled data for training. We propose a deep classification framework for enhancing mitosis detection by leveraging class label information, via softmax loss, and spatial distribution information among samples, via distance metric learning. We also investigate strategies towards steadily providing informative samples to boost the learning. The efficacy of the proposed framework is established through evaluation on ICPR 2012 and AMIDA 2013 mitotic data. Our framework significantly improves the detection with small training data and achieves on par or superior performance compared to state-of-the-art methods for using the entire training data.
△ Less
Submitted 2 July, 2020; v1 submitted 17 June, 2020;
originally announced June 2020.
